Paper22845893
Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.
Gatti A and 5 others. Pain Med, 2012. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis. Papers, record 22845893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22845893
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Chronic Pain | Major topic |
| Endocannabinoids | Major topic |
| Ethanolamines | Major topic |
| Palmitic Acids | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Amides | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Treatment Outcome | |
| Young Adult |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 23581707 | Emerging neuroprotective effects of N-palmitoylethanolamide besides its significant antinociceptive effects. | https://conductscience.org/library/papers/23581707 | PubMed |
| Comment in | 23614877 | Response to dr. Kapoor. | https://conductscience.org/library/papers/23614877 | PubMed |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42356281 | Palmitoylethanolamide/Baicalin Supplementation and Changes in Pain and Sudomotor Function in Type 2 Diabetes: A Retrospective Matched Real-World Cohort Study. | Nutrients | 2026 | https://conductscience.org/library/papers/42356281 | PubMed |
| 41709243 | Probiotics and palmitoylethanolamide (PEA) for osteoarthritic pain: individual effects in a multiple baseline design study. | BMC Complement Med Ther | 2026 | https://conductscience.org/library/papers/41709243 | PubMed |
| 41693292 | Palmitoylethanolamide (PEA) regulates cell cycle progression and promotes an anti-inflammatory transcriptomic signature in C2C12 skeletal muscle cells. | Physiol Rep | 2026 | https://conductscience.org/library/papers/41693292 | PubMed |
| 41390289 | Low-dose combination of ultramicronized palmitoylethanolamide and docosahexaenoic acid on neurosteroid and neuroinflammatory dysregulation in autism spectrum disorders. | Neurotherapeutics | 2026 | https://conductscience.org/library/papers/41390289 | PubMed |
| 41142233 | Pharmacologic treatment of fibromyalgia: an update. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41142233 | PubMed |
| 40853095 | Unlocking Relief: Investigating the Impact of a Fixed Combination of Acetyl-L-Carnitine and Palmitoylethanolamide on Traumatic Acute Low Back Pain. | Eur J Neurol | 2025 | https://conductscience.org/library/papers/40853095 | PubMed |
| 40563990 | Palmitoylethanolamide: A Multifunctional Molecule for Neuroprotection, Chronic Pain, and Immune Modulation. | Biomedicines | 2025 | https://conductscience.org/library/papers/40563990 | PubMed |
| 39630391 | A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review. | Pain Ther | 2025 | https://conductscience.org/library/papers/39630391 | PubMed |
| 39330506 | Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis. | Metabolites | 2024 | https://conductscience.org/library/papers/39330506 | PubMed |
| 39062193 | Effect of Palmitoylethanolamide Compared to a Placebo on the Gut Microbiome and Biochemistry in an Overweight Adult Population: A Randomised, Placebo Controlled, Double-Blind Study. | Biomedicines | 2024 | https://conductscience.org/library/papers/39062193 | PubMed |
| 38892586 | Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis. | Nutrients | 2024 | https://conductscience.org/library/papers/38892586 | PubMed |
| 38792328 | Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain Related to Chronic Inflammatory Demyelinating Polyneuropathy: A Proof-of-Concept Study. | J Clin Med | 2024 | https://conductscience.org/library/papers/38792328 | PubMed |
| 38790962 | Amelioration of Dextran Sodium Sulfate-Induced Colitis in Mice through Oral Administration of Palmitoylethanolamide. | Biomedicines | 2024 | https://conductscience.org/library/papers/38790962 | PubMed |
| 38399360 | Effectiveness of Palmitoylethanolamide (Levagen+) Compared to a Placebo for Reducing Pain, Duration, and Medication Use during Migraines in Otherwise Healthy Participants-A Double-Blind Randomised Controlled Study. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38399360 | PubMed |
| 37550909 | Neuropathic Pain in Aged People: An Unresolved Issue Open to Novel Drug Approaches, Focusing on Painful Diabetic Neuropathy. | Curr Neuropharmacol | 2024 | https://conductscience.org/library/papers/37550909 | PubMed |
| 37370671 | Quantification of Analgesic and Anti-Inflammatory Lipid Mediators in Long-Term Cryopreserved and Freeze-Dried Preserved Human Amniotic Membrane. | Bioengineering (Basel) | 2023 | https://conductscience.org/library/papers/37370671 | PubMed |
| 36638082 | Distribution of an analgesic palmitoylethanolamide and other N-acylethanolamines in human placental membranes. | PLoS One | 2023 | https://conductscience.org/library/papers/36638082 | PubMed |
| 36015298 | Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36015298 | PubMed |
| 35926992 | Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies. | BMJ Open | 2022 | https://conductscience.org/library/papers/35926992 | PubMed |
| 35578721 | Looking for Responders among Women with Chronic Pelvic Pain Treated with a Comicronized Formulation of Micronized Palmitoylethanolamide and Polydatin. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/35578721 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22845893
GET https://conductscience.org/api/papers/v1/22845893/cited_by?page=2